
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
USF-2 CRISPR/Cas9 KO Plasmid (m) | sc-423629 | 20 µg | $397.00 |
Upstream transcription factor 2 (USF-2), encoded by the mouse Usf2 gene, is a basic helix–loop–helix leucine zipper transcription factor that binds E-box motifs to regulate promoter activity across metabolic and stress-responsive gene networks. USF-2 participates in transcriptional control of glucose and lipid metabolism, cell-cycle progression, and differentiation programs, and it can modulate chromatin context through interactions with co-regulators. In murine systems, altered USF-2 activity has been linked to dysregulated metabolic homeostasis and changes in proliferative signaling, supporting its relevance to studies of cardiometabolic and cancer-associated pathways. Usf2 is therefore frequently investigated as a node connecting nutrient sensing, transcriptional circuitry, and tissue-specific gene expression.
USF-2 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Usf2 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Usf2 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Usf2 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish USF-2 protein expression.
This CRISPR knockout system enables efficient generation of Usf2-deficient cell models for investigation of USF-2 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.